Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1984 1
1985 2
1986 5
1987 5
1988 2
1989 3
1990 3
1991 5
1992 6
1993 7
1994 3
1995 13
1996 7
1997 12
1998 30
1999 22
2000 18
2001 17
2002 16
2003 33
2004 19
2005 24
2006 14
2007 15
2008 19
2009 16
2010 21
2011 20
2012 12
2013 20
2014 15
2015 27
2016 28
2017 31
2018 43
2019 48
2020 53
2021 58
2022 44
2023 54
2024 56
2025 50

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

795 results

Results by year

Filters applied: . Clear all
Page 1
Remibrutinib in Chronic Spontaneous Urticaria.
Metz M, Giménez-Arnau A, Hide M, Lebwohl M, Mosnaim G, Saini S, Sussman G, Szalewski R, Haemmerle S, Lheritier K, Martzloff ED, Seko N, Wang P, Zharkov A, Maurer M; REMIX-1 and REMIX-2 Investigators; REMIX-1 Investigators; REMIX-2 Investigators. Metz M, et al. Among authors: lebwohl m. N Engl J Med. 2025 Mar 6;392(10):984-994. doi: 10.1056/NEJMoa2408792. N Engl J Med. 2025. PMID: 40043237 Clinical Trial.
Bimekizumab versus Secukinumab in Plaque Psoriasis.
Reich K, Warren RB, Lebwohl M, Gooderham M, Strober B, Langley RG, Paul C, De Cuyper D, Vanvoorden V, Madden C, Cioffi C, Peterson L, Blauvelt A. Reich K, et al. Among authors: lebwohl m. N Engl J Med. 2021 Jul 8;385(2):142-152. doi: 10.1056/NEJMoa2102383. Epub 2021 Apr 23. N Engl J Med. 2021. PMID: 33891380 Clinical Trial.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K; TRuE-V Study Group. Rosmarin D, et al. Among authors: lebwohl m. N Engl J Med. 2022 Oct 20;387(16):1445-1455. doi: 10.1056/NEJMoa2118828. N Engl J Med. 2022. PMID: 36260792 Clinical Trial.
Psoriasis Comorbidities and Their Treatment Impact.
Taliercio M, Lebwohl M. Taliercio M, et al. Among authors: lebwohl m. Dermatol Clin. 2024 Jul;42(3):405-416. doi: 10.1016/j.det.2024.02.007. Epub 2024 Mar 13. Dermatol Clin. 2024. PMID: 38796272 Review.
Trial of Spesolimab for Generalized Pustular Psoriasis.
Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, Navarini AA, Zheng M, Xu J, Turki H, Anadkat MJ, Rajeswari S, Hua H, Vulcu SD, Hall D, Tetzlaff K, Thoma C, Lebwohl MG; Effisayil 1 Trial Investigators. Bachelez H, et al. Among authors: lebwohl mg. N Engl J Med. 2021 Dec 23;385(26):2431-2440. doi: 10.1056/NEJMoa2111563. N Engl J Med. 2021. PMID: 34936739 Free article. Clinical Trial.
Current management of generalized pustular psoriasis.
Kodali N, Blanchard I, Kunamneni S, Lebwohl MG. Kodali N, et al. Among authors: lebwohl mg. Exp Dermatol. 2023 Aug;32(8):1204-1218. doi: 10.1111/exd.14765. Epub 2023 Mar 1. Exp Dermatol. 2023. PMID: 36779681 Review.
Psoriasis management tree based on comorbidity.
Amara S, Pasumarthi A, Parikh N, Kodali N, Lebwohl M, Monks G. Amara S, et al. Among authors: lebwohl m. Int J Dermatol. 2025 Feb;64(2):229-245. doi: 10.1111/ijd.17497. Epub 2024 Oct 17. Int J Dermatol. 2025. PMID: 39420121 Review.
795 results